282 related articles for article (PubMed ID: 30716317)
1. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Ismail NM
Eur J Pharmacol; 2019 May; 850():75-87. PubMed ID: 30716317
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Johari B; Mohd Ismail N
Eur J Pharm Sci; 2018 Mar; 114():245-254. PubMed ID: 29274441
[TBL] [Abstract][Full Text] [Related]
3. Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
Razali N; Agarwal R; Agarwal P; Tripathy M; Kapitonova MY; Kutty MK; Smirnov A; Khalid Z; Ismail NM
Exp Eye Res; 2016 Feb; 143():9-16. PubMed ID: 26424219
[TBL] [Abstract][Full Text] [Related]
4. Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
Razali N; Agarwal R; Agarwal P; Kapitonova MY; Kannan Kutty M; Smirnov A; Salmah Bakar N; Ismail NM
Eur J Pharmacol; 2015 Feb; 749():73-80. PubMed ID: 25481859
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
[TBL] [Abstract][Full Text] [Related]
6. Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Mohd Ismail N
Data Brief; 2018 Jun; 18():523-554. PubMed ID: 29896529
[TBL] [Abstract][Full Text] [Related]
7. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
[TBL] [Abstract][Full Text] [Related]
8. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-β2 signaling pathways.
Razali N; Agarwal R; Agarwal P; Froemming GRA; Tripathy M; Ismail NM
Eur J Pharmacol; 2018 Nov; 838():1-10. PubMed ID: 30171854
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
[TBL] [Abstract][Full Text] [Related]
10. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
[TBL] [Abstract][Full Text] [Related]
11. Topical ocular dexamethasone decreases intraocular pressure and body weight in rats.
Sato K; Nishiguchi KM; Maruyama K; Moritoh S; Fujita K; Ikuta Y; Kasai H; Nakazawa T
J Negat Results Biomed; 2016 Mar; 15():5. PubMed ID: 26971048
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
Abbhi V; Saini L; Mishra S; Sethi G; Kumar AP; Piplani P
Bioorg Med Chem; 2017 Nov; 25(21):6071-6085. PubMed ID: 29033348
[TBL] [Abstract][Full Text] [Related]
13. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
Shaw PX; Sang A; Wang Y; Ho D; Douglas C; Dia L; Goldberg JL
Exp Eye Res; 2017 May; 158():33-42. PubMed ID: 27443501
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
[TBL] [Abstract][Full Text] [Related]
15. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
[No Abstract] [Full Text] [Related]
16. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
[TBL] [Abstract][Full Text] [Related]
17. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
[TBL] [Abstract][Full Text] [Related]
18. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
Stankowska DL; Millar JC; Kodati B; Behera S; Chaphalkar RM; Nguyen T; Nguyen KT; Krishnamoorthy RR; Ellis DZ; Acharya S
Mol Vis; 2021; 27():37-49. PubMed ID: 33633438
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
